Sanofi Consumer Healthcare India Limited has informed the Exchange regarding disclosure received from Opal Bidco SAS, in relation to acquisition of equity share of the Company pursuant to Open Offer under SEBI (SAST) Regulations, 2011

Open Offer TriggeredListed Co AcquisitionStrategic Transactions View source PDF Explain this filing

SANOFICONR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.0%Reaction day

₹5076.50

prior close

₹5056.00

announcement price

After-mkt

timing

Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.3%-0.3% vs market

Pharmaceuticals peers, median of 150sector-0.5%+0.4% vs sector

On the reaction day the stock moved 0.3 pts less than Nifty Microcap 250 and 0.4 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

-0.7

15m

-0.4

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.0+0.3-0.3-0.5+0.4

Next day

-0.5-0.7+0.1-1.7+1.2

-0.0-1.0+0.9-2.1+2.0

-1.2-2.8+1.6-4.0+2.8

-0.5-2.5+2.0-3.4+2.9

-2.2-2.2-0.0-3.3+1.0

-0.3+0.1-0.4-1.5+1.2

15d

+4.5+1.4+3.1-0.6+5.1

+0.6+3.5-3.0+1.0-0.4

+4.8-1.6+6.4-3.9+8.7

+4.4+1.0+3.4-2.4+6.8

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 150Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Opal Bidco SAS, a member of the promoter group based in Paris, acquired 25,04,630 equity shares of Sanofi Consumer Healthcare India Limited, representing 10.87% of the company's total share capital, for a total consideration of approximately ₹1,247.82 crore. The acquisition was executed off-market on June 11, 2025, pursuant to an open offer triggered under SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This open offer was triggered because Opal Bidco SAS indirectly acquired 100% of Opella Healthcare Participations BV, which already holds 1,39,09,587 equity shares (about 60.4%) in the company. The disclosure was filed under the SEBI Insider Trading Regulations and received by the company on June 12, 2025.

Likely market impact

For shareholders, this confirms that the promoter group's stake in Sanofi Consumer Healthcare India has increased further through the open offer process, consolidating control. The stock may see reduced trading liquidity post-open offer, and minority shareholders had an opportunity to tender shares at the open offer price.